Analysis of Retina and Erythrocyte Glycerophospholipid Alterations in a Rat Model of Type 1 Diabetes

Journal of Laboratory Automation

Volumn 14, Issue 6, 2009, Pages 383-399

  Lydic, Todd A ^a   Renis, Rebecca ^a   Busik, Julia V ^a   Reid, Gavin E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

diabetic; electrospray; ionization; lipidomics; retina; retinopathy; tandem mass spectrometry

Indexed keywords

DIABETIC RATS; DIABETIC RETINOPATHY; DOCOSAHEXAENOIC ACID; GLYCEROPHOSPHOLIPIDS; INTERNAL STANDARDS; LABEL FREE; LINOLEIC ACID; LIPID EXTRACT; LIPIDOMES; LIPIDOMICS; METHODS OF ANALYSIS; NEUTRAL LOSS; NON-DIABETIC CONTROL; RAT MODEL; STREPTOZOTOCIN; TANDEM MASS SPECTROMETRY; TRIPLE QUADRUPOLE; TYPE 1 DIABETES;

ACIDS; ANIMALS; EYE PROTECTION; FATTY ACIDS; GLUCOSE; IONIZATION; LIPIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PARTICLE DETECTORS; RATS; STANDARDS; SUGAR (SUCROSE);

ELECTROSPRAY IONIZATION;

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; GLYCEROPHOSPHOETHANOLAMINE; LINOLEIC ACID; LIPIDOME; PHOSPHATIDYLCHOLINE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTROSPRAY MASS SPECTROMETRY; ERYTHROCYTE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; LIPID COMPOSITION; MALE; NONHUMAN; PHOSPHOLIPID METABOLISM; RAT; RETINA; STREPTOZOCIN DIABETES;

EID: 71649097250     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2009.07.003     Document Type: Article

References (84)

1. Labaer J. So, you want to look for biomarkers. J Proteome Res 2005, 4(4), 1053–1059.
2. Semmes O. J. Malik G. Ward M. Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. J Cell Biochem 2006, 98(3), 496–503.
3. Wenk M. R. The emerging field of lipidomics. Nat Rev Drug Discov 2005, 4(7), 594–610.
4. Metz T. Qian W.-J. Jacobs J. M. Gritsenko M. Moore R. Polpitiya A. Monroe M. Camp D. Mueller P. Smith R. Application of Proteomics in the Discovery of Candidate Protein Biomarkers in a Diabetes Autoantibody Standardization Program Sample Subset. J. Prot. Res 2008, 7, 698–707.
5. Anderson N. L. Anderson N. G. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1(11), 845–867.
6. Van Meer G. Cellular lipidomics. Embo J 2005, 24(18), 3159–3165.
7. Han X. G. R. Specific lipid alterations in Alzheimer's disease and diabetes: Shotgun global cellular lipidome analyses by electrospray ionization mass spectrometry using intrasource separation In Functional Lipidomics; Feng L. Prestwich G., Eds.; CRC Press LLC: Boca Raton, FL; 2006; pp. 286–306.
8. Han X. Yang J. Yang K. Zhongdan Z. Abendschein D. R. Gross R. W. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: A shotgun lipidomics study. Biochemistry 2007, 46, 6417–6428.
9. Ford D. Monda J. Brush R. Anderson R. Richards M. Fliesler S. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: Alterations in docosahexaenoic acid content of phospholipid molecular species. J Neurochem 2008, 105, 1032–1047.
10. Gross R. Han X. Lipidomics in diabetes and the metabolic syndrome. Methods in Enzymology 2007, 433, 73–90.
11. Sangiovanni J. P. Chew E. Y. Clemons T. E. Davis M. D. Ferris F. L. 3rd Gensler G. R. Kurinij N. Lindblad A. S. Milton R. C. Seddon J. M. Sperduto R. D. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007, 125(5), 671–679.
12. Connor K. M. Sangiovanni J. P. Lofqvist C. Aderman C. M. Chen J. Higuchi A. Hong S. Pravda E. A. Majchrzak S. Carper D. Hellstrom A. Kang J. X. Chew E. Y. Salem N. Jr. Serhan C. N. Smith L. E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007, 13(7), 868–873.
13. Klein R. Klein B. E. Moss S. E. Cruickshanks K. J. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994, 112(9), 1217–1228.
14. Joussen A. M. Poulaki V. Le M. L. Koizumi K. Esser C. Janicki H. Schraermeyer U. Kociok N. Fauser S. Kirchhof B. Kern T. S. Adamis A. P. A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 2004, 18(12), 1450–1452.
15. Anderson R. E. Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. Exp Eye Res 1970, 10(2), 339–344.
16. Fliesler S. J. Anderson R. E. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983, 22(2), 79–131.
17. Lecomte M. Paget C. Ruggiero D. Wiernsperger N. Lagarde M. Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem 1996, 66(5), 2160–2167.
18. O’Brien J. S. Sampson E. L. Lipid composition of the normal human brain: Gray matter, white matter, and myelin. J Lipid Res 1965, 6(4), 537–544.
19. Sangiovanni J. P. Chew E. Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005, 24(1), 87–138.
20. Weisinger H. S. Armitage J. A. Jeffrey B. G. Mitchell D. C. Moriguchi T. Sinclair A. J. Weisinger R. S. Salem N. Jr. Retinal sensitivity loss in third-generation n-3 PUFA-deficient rats. Lipids 2002, 37(8), 759–765.
21. Birch E. E. Garfield S. Castaneda Y. Hughbanks-Wheaton D. Uauy R. Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 2007, 83 (5), 279–284.
22. Ren H. Magulike N. Ghebremeskel K. Crawford M. Primary openangle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids 2006, 74(3), 157–163.
23. Hartong D. T. Berson E. L. Dryja T. P. Retinitis pigmentosa. Lancet 2006, 368(9549), 1795–1809.
24. Hoffman D. R. Birch D. G. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 1995, 36(6), 1009–1018.
25. Schaefer E. J. Robins S. J. Patton G. M. Sandberg M. A. Weigel-Difranco C. A. Rosner B. Berson E. L. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J Lipid Res 1995, 36(7), 1427–1433.
26. Schroder S. Palinski W. Schmid-Schonbein G. W. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991, 139(1), 81–100.
27. Joussen A. M. Poulaki V. Mitsiades N. Kirchhof B. Koizumi K. Dohmen S. Adamis A. P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. Faseb J 2002, 16(3), 438–440.
28. Joussen A. M. Poulaki V. Qin W. Kirchhof B. Mitsiades N. Wiegand S. J. Rudge J. Yancopoulos G. D. Adamis A. P. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 2002, 160(2), 501–509.
29. Joussen A. M. Murata T. Tsujikawa A. Kirchhof B. Bursell S. E. Adamis A. P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001, 158(1), 147–152.
30. McLeod D. S. Lefer D. J. Merges C. Lutty G. A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995, 147(3), 642–653.
31. Miyamoto K. Khosrof S. Bursell S. E. Rohan R. Murata T. Clermont A. C. Aiello L. P. Ogura Y. Adamis A. P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A 1999, 96(19), 10836–10841.
32. Chen W. Jump D. B. Grant M. B. Esselman W. J. Busik J. V. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2003, 44(11), 5016–5022.
33. Chen W. Esselman W. J. Jump D. B. Busik J. V. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2005, 46(11), 4342–4347.
34. Chen W. Jump D. B. Esselman W. J. Busik J. V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007, 48(1), 18–26.
35. Futterman S. Kupfer C. The fatty acid composition of the retinal vasculature of normal and diabetic human eyes. Invest Ophthalmol 1968, 7(1), 105–108.
36. Suh M. Wierzbicki A. A. Clandinin M. T. Dietary fat alters membrane composition in rod outer segments in normal and diabetic rats: Impact on content of very-long-chain (C < or = 24) polyenoic fatty acids. Biochim Biophys Acta 1994, 1214(1), 54–62.
37. Fox T. E. Han X. Kelly S. Merrill A. H. 2nd Martin R. E. Anderson R. E. Gardner T. W. Kester M. Diabetes alters sphingolipid metabolism in the retina: A potential mechanism of cell death in diabetic retinopathy. Diabetes 2006, 55(12), 3573–3580.
38. Watson A. D. Lipidomics: A global approach to lipid analysis in biological systems. J Lipid Res 2006, 47(10), 2101–2111.
39. Brugger B. Erben G. Sandhoff R. Wieland F. T. Lehmann W. D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A 1997, 94(6), 2339–2344.
40. Ejsing C. S. Duchoslav E. Sampaio J. Simons K. Bonner R. Thiele C. Ekroos K. Shevchenko A. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 2006, 78(17), 6202–6214.
41. Han X. Gross R. W. Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 2005, 24(3), 367–412.
42. Pulfer M. Murphy R. C. Electrospray mass spectrometry of phospholipids. Mass Spectrom Rev 2003, 22(5), 332–364.
43. Schwudke D. Oegema J. Burton L. Entchev E. Hannich J. T. Ejsing C. S. Kurzchalia T. Shevchenko A. Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal Chem 2006, 78(2), 585–595.
44. Welti R. Wang X. Williams T. D. Electrospray ionization tandem mass spectrometry scan modes for plant chloroplast lipids. Anal Biochem 2003, 314(1), 149–152.
45. Welti R. Shah J. Levine S. Esch S. W. Williams T. D. Wang X. High throughput lipid profiling to identify and characterize genes involved in lipid metabolism, signaling, and stress response In Functional Lipidomics; Feng L. Prestwich G. D., Eds.; Marcel Dekker: New York; 2005.
46. Jones J. J. Stump M. J. Fleming R. C. Lay J. O. Jr. Wilkins C. L. Strategies and data analysis techniques for lipid and phospholipid chemistry elucidation by intact cell MALDI-FTMS. J Am Soc Mass Spectrom 2004, 15(11), 1665–1674.
47. Jones J. J. Batoy S. M. Wilkins C. L. A comprehensive and comparative analysis for MALDI FTMS lipid and phospholipid profiles from biological samples. Comput Biol Chem 2005, 29(4), 294–302.
48. Jones J. J. Borgmann S. Wilkins C. L. O’Brien R. M. Characterizing the phospholipid profiles in mammalian tissues by MALDI FTMS. Anal Chem 2006, 78(9), 3062–3071.
49. Estrada R. Yappert M. C. Alternative approaches for the detection of various phospholipid classes by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mass Spectrometry 2004, 39, 412–422.
50. Han X. Gross R. W. Shotgun lipidomics: Multidimensional MS analysis of cellular lipidomes. Expert Rev Proteomics 2005, 2(2), 253–264.
51. Ekroos K. Chernushevich I. V. Simons K. Shevchenko A. Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal Chem 2002, 74(5), 941–949.
52. Kerwin J. L. Tuininga A. R. Ericsson L. H. Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. J Lipid Res 1994, 35(6), 1102–1114.
53. Han X. Gross R. W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics. J Lipid Res 2003, 44(6), 1071–1079.
54. Merrill A. H. Sullards M. C. Allegood J. C. Kelly S. Wang E. Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005, 36(2), 207–224.
55. Welti R. Li W. Li M. Sang Y. Biesiada H. Zhou H. E. Rajashekar C. B. Williams T. D. Wang X. Profiling membrane lipids in plant stress responses. Role of phospholipase D alpha in freezing-induced lipid changes in Arabidopsis. J Biol Chem 2002, 277(35), 31994–32002.
56. Koivusalo M. Haimi P. Heikinheimo L. Kostiainen R. Somerharju P. Quantitative determination of phospholipid compositions by ESI-MS: Effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lipid Res 2001, 42, 663–672.
57. Delong C. J. Baker P. R. Samuel M. Cui Z. Thomas M. J. Molecular species composition of rat liver phospholipids by ESI-MS/MS: The effect of chromatography. J Lipid Res 2001, 42(12), 1959–1968.
58. Song H. Ladenson J. Turk J. Algorithms for automatic processing of data from mass spectrometric analyses of lipids. J Chromatogr B Analyt Technol Biomed Life Sci 2008.
59. Ivanova P. T. Milne S. B. Byrne M. O. Xiang Y. Brown H. A. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol 2007, 432, 21–57.
60. Murphy R. C. James P. F. McAnoy A. M. Krank J. Duchoslav E. Barkley R. M. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 2007, 366(1), 59–70.
61. Ivanova P. T. Milne S. B. Forrester J. S. Brown H. A. LIPID arrays: New tools in the understanding of membrane dynamics and lipid signaling. Mol Interv 2004, 4(2), 86–96.
62. Turck C. W. Falick A. M. Kowalak J. A. Lane W. S. Lilley K. S. Phinney B. S. Weintraub S. T. Witkowska H. E. Yates N. A. The Association of Biomolecular Resource Facilities Proteomics Research Group 2006 study: Relative protein quantitation. Mol Cell Proteomics 2007, 6(8), 1291–1298.
63. Old W. M. Meyer-Arendt K. Aveline-Wolf L. Pierce K. G. Mendoza A. Sevinsky J. R. Resing K. A. Ahn N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005, 4(10), 1487–1502.
64. Lydic T. A. Busik J. V. Esselman W. J. Reid G. E. Complementary precursor ion and neutral loss scan mode tandem mass spectrometry for the analysis of glycerophosphatidylethanolamine lipids from whole rat retina. Anal Bioanal Chem 2009.
65. Rose H. Oklander M. An improved method for the extraction of lipids from human erythrocytes. J Lipid Res 1965, 6, 428–431.
66. Nakagawa K. Oak J. H. Higuchi O. Tsuzuki T. Oikawa S. Otani H. Mune M. Cai H. Miyazawa T. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes. J Lipid Res 2005, 46(11), 2514–2524.
67. Haimi P. Uphoff A. Hermansson M. Somerharju P. Software tools for analysis of mass spectrometric lipidome data. Anal Chem 2006, 78(24), 8324–8331.
68. Zhang X. Reid G. E. Multistage tandem mass spectrometry of anionic phosphatidylcholine lipid adducts reveals novel dissociation pathways. Inte J Mass Spectrometry 2006, 252(3), 242–255.
69. Brucklacher R. M. Patel K. M. Vanguilder H. D. Bixler G. V. Barber A. J. Antonetti D. A. Lin C. M. Lanoue K. F. Gardner T. W. Bronson S. K. Freeman W. M. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics 2008, 1, 26.
70. Decsi T. Minda H. Hermann R. Kozari A. Erhardt E. Burus I. Molnar S. Soltesz G. Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic children. Prostaglandins Leukot Essent Fatty Acids 2002, 67(4), 203–210.
71. Decsi T. Szabo E. Burus I. Marosvolgyi T. Kozari A. Erhardt E. Soltesz G. Low contribution of n-3 polyunsaturated fatty acids to plasma and erythrocyte membrane lipids in diabetic young adults. Prostaglandins Leukot Essent Fatty Acids 2007, 76(3), 159–164.
72. Han X. Gross R. Structural Determination of Picomole Amounts of Phospholipids Via Electrospray Ionization Tandem Mass Spectrometry. J Am Soc Mass Spectrometry 1995, 6, 1202–1210.
73. Vinores S. A. Derevjanik N. L. Ozaki H. Okamoto N. Campochiaro P. A. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 1999, 97(3–4), 217–228.
74. Martin S. L. Hoffman W. H. Marcus D. M. Passmore G. G. Dalton R. R. Retinal vascular integrity following correction of diabetic ketoacidosis in children and adolescents. J Diabetes Complications 2005, 19(4), 233–237.
75. Ahmed N. Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes Res Clin Pract 2005, 67(1), 3–21.
76. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994, 43(6), 836–841.
77. Baynes J. W. Thorpe S. R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000, 28(12), 1708–1716.
78. Jakus V. Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004, 53(2), 131–142.
79. Gardiner T. A. Anderson H. R. Stitt A. W. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol 2003, 201(2), 328–333.
80. Kern T. S. Engerman R. L. Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes 2001, 50(7), 1636–1642.
81. Ravandi A. Kuksis A. Marai L. Myher J. J. Steiner G. Lewisa G. Kamido H. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett 1996, 381(1–2), 77–81.
82. Nakagawa K. Oak J. H. Miyazawa T. Angiogenic potency of Amadori-glycated phosphatidylethanolamine. Ann N Y Acad Sci 2005, 1043, 413–416.
83. Oak J. H. Nakagawa K. Oikawa S. Miyazawa T. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett 2003, 555(2), 419–423.
84. Navaratna D. McGuire P. G. Menicucci G. Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 2007, 56(9), 2380–2387.